IGF1 and acromegaly: Their levels have been associated with prognosis [21]: in particular lowering GH to “safe” levels and normalizing IGF-I in patients with acromegaly results in mortality rates similar to those expected in the general population, as recommended by guidelines [2, 12, 13].